Covalon Technologies Ltd.
OTC: CVALF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brent Ashton
- Employees
- 105
- Headquarters
- Mississauga, Canada
- IPO year
- 2007
- Market cap
- $43.1M
- Website
- https://www.covalon.com
Loading CVALF…
Loading profile data…Frequently asked questions about CVALF
What does Covalon Technologies Ltd. (CVALF) do?
Covalon Technologies Ltd. is a global medical technology firm specializing in the innovation, production, commercialization, and licensing of medical solutions across the United States, Canada, Europe, the Middle East, Asia, and Latin America. The company's operations are built upon three distinct proprietary technological platforms. The first,...
Where does CVALF trade?
Covalon Technologies Ltd. (CVALF) trades on the Other OTC.
What sector is CVALF in?
Covalon Technologies Ltd. (CVALF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Covalon Technologies Ltd.?
Brent Ashton is the chief executive officer of Covalon Technologies Ltd. (CVALF).
Where is Covalon Technologies Ltd. headquartered?
Covalon Technologies Ltd. is headquartered in Canada.
Does CVALF pay a dividend?
Yes — Covalon Technologies Ltd. (CVALF) paid a trailing twelve-month dividend of USD 0.11 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CVALF go public?
Covalon Technologies Ltd. (CVALF) completed its initial public offering in 2007.